The Director, HTA, Value & Evidence (HV&E) – Breast Cancer will support the strategic goals of the Oncology Division by driving optimal patient access for Pfizer’s portfolio of breast cancer medicines, with a focus on Ibrance
Job Summary
The Director, HTA, Value & Evidence (HV&E) – Breast Cancer will support the strategic goals of the Oncology Division by driving optimal patient access for Pfizer’s portfolio of breast cancer medicines, with a focus on Ibrance.
This position will be part of Pfizer’s dynamic Global Access & Value (GAV) team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to breast cancer medicines, with a primary focus on Ibrance.
The annual base salary for this position ranges from $176,600.00 to $294,300.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program.
Matching Summary
The Director, HTA, Value & Evidence (HV&E) – Breast Cancer will support the strategic goals of the Oncology Division by driving optimal patient access for Pfizer’s portfolio of breast cancer medicines, with a focus on Ibrance.
Salary
Base: $176,600.00 - $294,300.00; Bonus/Equity: 20.0% bonus target; Benefits: Comprehensive and generous benefits and programs